Medtronic, Inc. (NYSE:MDT) announced that a jury in the United States District Court of the Southern District of California in San Diego, found that NuVasive's CoRoent XL implants, MaXcess II and III retractors, and Helix and Helix mini anterior cervical plates infringe three patents owned by Medtronic. The jury awarded Medtronic $101.2 million in damages.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. It provides implantable cardioverter-defibrillators, cardiac resynchronization therapy devices, and cardiac pacemakers for the diagnosis, treatment, and management of heart rhythm disorders and heart failure; AF products; diagnostics and monitoring devices; and patient management tools.

Read the full article and the disclaimer at: http://drstockpick.com/?p=22145